THERAPEUTIC SPLICE-SWITCHING OLIGONUCLEOTIDES
The present disclosure provides compositions and methods for treating a disorder associated with mutations in the CEP290 gene. The disclosure includes synthetic polynucleotides for skipping a reading-frame of a CEP290 pre-RNA, yielding a CEP290 translated product that lacks one or more exons. The di...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French |
Published |
27.02.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present disclosure provides compositions and methods for treating a disorder associated with mutations in the CEP290 gene. The disclosure includes synthetic polynucleotides for skipping a reading-frame of a CEP290 pre-RNA, yielding a CEP290 translated product that lacks one or more exons. The disclosure also provides methods of treating patients with the synthetic polynucleotides disclosed herein.
La présente invention concerne des compositions et des méthodes pour le traitement d'un trouble associé à des mutations dans le gène CEP290. L'invention comprend des polynucléotides synthétiques pour sauter un cadre de lecture d'un pré-ARN de CEP290, produisant un produit traduit de CEP290 qui est dépourvu d'un ou de plusieurs exons. L'invention concerne également des méthodes de traitement de patients avec les polynucléotides synthétiques décrits ici. |
---|---|
AbstractList | The present disclosure provides compositions and methods for treating a disorder associated with mutations in the CEP290 gene. The disclosure includes synthetic polynucleotides for skipping a reading-frame of a CEP290 pre-RNA, yielding a CEP290 translated product that lacks one or more exons. The disclosure also provides methods of treating patients with the synthetic polynucleotides disclosed herein.
La présente invention concerne des compositions et des méthodes pour le traitement d'un trouble associé à des mutations dans le gène CEP290. L'invention comprend des polynucléotides synthétiques pour sauter un cadre de lecture d'un pré-ARN de CEP290, produisant un produit traduit de CEP290 qui est dépourvu d'un ou de plusieurs exons. L'invention concerne également des méthodes de traitement de patients avec les polynucléotides synthétiques décrits ici. |
Author | WIENHOLDS, ERNO SUN, MARK GEORGE FORD MERICO, DANIELE GONCALVES, JOAO ANTONIO LOURENCO |
Author_xml | – fullname: WIENHOLDS, ERNO – fullname: SUN, MARK GEORGE FORD – fullname: GONCALVES, JOAO ANTONIO LOURENCO – fullname: MERICO, DANIELE |
BookMark | eNrjYmDJy89L5WTQDfFwDXIMcA0N8XRWCA7w8XR21Q0O9wxx9vD0c1fw9_F09_cLdfZx9Q_xdHEN5mFgTUvMKU7lhdLcDApurkC1uqkF-fGpxQWJyal5qSXxzo7GhgbmFpYGjobGRCgBAJIaJyQ |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | OLIGONUCLEOTIDES A PERMUTATION D'EPISSAGE THERAPEUTIQUES |
ExternalDocumentID | CA3107890A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA3107890A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:11:43 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA3107890A13 |
Notes | Application Number: CA20193107890 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200227&DB=EPODOC&CC=CA&NR=3107890A1 |
ParticipantIDs | epo_espacenet_CA3107890A1 |
PublicationCentury | 2000 |
PublicationDate | 20200227 |
PublicationDateYYYYMMDD | 2020-02-27 |
PublicationDate_xml | – month: 02 year: 2020 text: 20200227 day: 27 |
PublicationDecade | 2020 |
PublicationYear | 2020 |
RelatedCompanies | DEEP GENOMICS INCORPORATED |
RelatedCompanies_xml | – name: DEEP GENOMICS INCORPORATED |
Score | 3.253893 |
Snippet | The present disclosure provides compositions and methods for treating a disorder associated with mutations in the CEP290 gene. The disclosure includes... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA DERIVATIVES THEREOF ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS SUGARS VINEGAR WINE |
Title | THERAPEUTIC SPLICE-SWITCHING OLIGONUCLEOTIDES |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200227&DB=EPODOC&locale=&CC=CA&NR=3107890A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8haNSbokb8yg5mt8bBPnCHxYyuk5mxLWxTboSOLeECRGb8931tBnrRW9OX9Ct5ff299vcrwMOiMov5k64RvrA0IrQwCcJmm-h6MUC40OO6JbjD48ga5cbr1Jy2YLnjwkid0C8pjogeVaC_13K_3vwksTz5tnL7yJdYtX72M8dTG3Tcl4p4qjd0WBJ7MVUpdairRhORxxaUTxeB0oFQ3RIy--xtKEgpm98RxT-FwwQbW9Vn0CpXHTimu4_XOnA0bu67sdi43vYcSDZiEzdheRZQJU3CgDKSvgcZFfkmJQ6DlzjKacjiLPBYegGKz9BGsN_Zfo4z6u5HqF9CG6F_eQVKr-TaoMITzlwzDJ2XdmUIvS6rX5rojdzuQvfPZq7_sd3AiVgsSc0e3EK7_vgs7zC41vxeLss3Zrx4YQ |
link.rule.ids | 230,308,780,885,25564,76547 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PT4MwFH5ZpnHedGqcPzkYbo1sMJADMawUhzIgA3S3ZWUs2WUuDuO_72vDphe9NW3SHy95ff1e-30FuJsv-sXsQdcIn5saEVqYBGGzTXS9sBAudLluCu7wKDKHufE86U8asNxyYaRO6JcUR0SPKtDfK7lfr3-SWJ58W7m550usen_0M8dTa3Tck4p4qjdwWBJ7MVUpdairRmORxxaUTxeB0p4lPtwVJ6fXgSClrH9HFP8I9hPsbFUdQ6NctaFFtx-vteFgVN93Y7F2vc0JkGzIxm7C8iygSpqEAWUkfQsyKvJNShwGT3GU05DFWeCx9BQUn2EbwXGnuzVOqbuboX4GTYT-5Tko3ZJr1gJPODPNMHRe2gtD6HWZvbKP3sjtDnT-7Obin7ZbaA2zUTgNg-jlEg6F4SRN27qCZvXxWV5joK34jTTRNzSve1I |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=THERAPEUTIC+SPLICE-SWITCHING+OLIGONUCLEOTIDES&rft.inventor=WIENHOLDS%2C+ERNO&rft.inventor=SUN%2C+MARK+GEORGE+FORD&rft.inventor=GONCALVES%2C+JOAO+ANTONIO+LOURENCO&rft.inventor=MERICO%2C+DANIELE&rft.date=2020-02-27&rft.externalDBID=A1&rft.externalDocID=CA3107890A1 |